Literature DB >> 1535663

Huntington's disease and the ethics of genetic prediction.

G Terrenoire1.   

Abstract

What ethical justification can be found for informing a person that he or she will later develop a lethal disease for which no therapy is available? This question has been discussed during the past twenty years by specialists concerned with the prevention of Huntington's Disease, an incurable late-onset hereditary disorder. Many of them have played an active role in developing experimental testing programmes for at-risk persons. This paper is based on a corpus of 119 articles; it reviews the development of their reflection and includes an outline of the ethical problems identified and the solutions adopted in pre-clinical protocols. Seen in a broader perspective, the experience of presymptomatic testing for Huntington's Disease has given medical geneticists the opportunity to clarify their ethical position in the as yet little explored field of predictive medicine.

Entities:  

Keywords:  Analytical Approach; Genetics and Reproduction

Mesh:

Substances:

Year:  1992        PMID: 1535663      PMCID: PMC1376112          DOI: 10.1136/jme.18.2.79

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  61 in total

1.  Ethical considerations in research on Huntington's disease.

Authors:  C R MacKay; J M Shea
Journal:  Clin Res       Date:  1977-10

2.  National symposium on problems of presymptomatic testing for Huntington's disease, Cardiff.

Authors:  A Tyler; M Morris
Journal:  J Med Ethics       Date:  1990-03       Impact factor: 2.903

3.  Problems in genetic prediction for Huntington's disease.

Authors:  M J Morris; A Tyler; L Lazarou; L Meredith; P S Harper
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

4.  [DNA diagnosis of Huntington's chorea. Application and genetic counseling in 4 involved families].

Authors:  J Hammer; M Mächler; W Schmid
Journal:  Schweiz Med Wochenschr       Date:  1987-12-19

5.  The decision to be tested for Huntington's disease.

Authors:  K A Quaid; J Brandt; S E Folstein
Journal:  JAMA       Date:  1987-06-26       Impact factor: 56.272

6.  Knowledge, attitude, and the decision to be tested for Huntington's disease.

Authors:  K A Quaid; J Brandt; R R Faden; S E Folstein
Journal:  Clin Genet       Date:  1989-12       Impact factor: 4.438

7.  Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.

Authors:  M Bloch; M Fahy; S Fox; M R Hayden
Journal:  Am J Med Genet       Date:  1989-02

8.  The motivation of at-risk individuals and their partners in deciding for or against predictive testing for Huntington's disease.

Authors:  G Evers-Kiebooms; A Swerts; J J Cassiman; H Van den Berghe
Journal:  Clin Genet       Date:  1989-01       Impact factor: 4.438

9.  Different options for prenatal testing for Huntington's disease using DNA probes.

Authors:  M Fahy; C Robbins; M Bloch; R W Turnell; M R Hayden
Journal:  J Med Genet       Date:  1989-06       Impact factor: 6.318

10.  Attitudes toward presymptomatic testing in Huntington disease.

Authors:  C Mastromauro; R H Myers; B Berkman
Journal:  Am J Med Genet       Date:  1987-02
View more
  6 in total

1.  Testing for Huntington's disease.

Authors:  R Williamson
Journal:  BMJ       Date:  1992-06-20

2.  Preparing for presymptomatic DNA testing for early onset Alzheimer's disease/cerebral haemorrhage and hereditary Pick disease.

Authors:  A Tibben; M Stevens; G M de Wert; M F Niermeijer; C M van Duijn; J C van Swieten
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

3.  Huntington disease: prenatal screening for late onset disease.

Authors:  J Greenberg
Journal:  J Med Ethics       Date:  1993-06       Impact factor: 2.903

4.  Genomic Essentialism: Its Provenance and Trajectory as an Anticipatory Ethical Concern.

Authors:  Maya Sabatello; Eric Juengst
Journal:  Hastings Cent Rep       Date:  2019-05       Impact factor: 2.683

Review 5.  Genetic Testing for Rare Diseases: A Systematic Review of Ethical Aspects.

Authors:  Judith Kruse; Regina Mueller; Ali A Aghdassi; Markus M Lerch; Sabine Salloch
Journal:  Front Genet       Date:  2022-01-26       Impact factor: 4.599

6.  'I Don't Like Uncertainty, I Like to Know': How and why uveal melanoma patients consent to life expectancy prognostication.

Authors:  Stephen L Brown; Peter L Fisher; Andrew Morgan; Cari Davies; Yasmin Olabi; Laura Hope-Stone; Heinrich Heimann; Rumana Hussain; Mary Gemma Cherry
Journal:  Health Expect       Date:  2022-04-26       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.